289 related articles for article (PubMed ID: 19667249)
1. Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.
Ohtsubo T; Matsumura K; Sakagami K; Fujii K; Tsuruya K; Noguchi H; Rovira II; Finkel T; Iida M
Hypertension; 2009 Oct; 54(4):868-76. PubMed ID: 19667249
[TBL] [Abstract][Full Text] [Related]
2. Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes.
Murakami N; Ohtsubo T; Kansui Y; Goto K; Noguchi H; Haga Y; Nakabeppu Y; Matsumura K; Kitazono T
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):44-51. PubMed ID: 24158515
[TBL] [Abstract][Full Text] [Related]
3. Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.
Ishii T; Kumagae T; Wakui H; Urate S; Tanaka S; Abe E; Suzuki T; Yamaji T; Kinguchi S; Kobayashi R; Haruhara K; Nakamura T; Kobayashi S; Tamura K
FEBS Open Bio; 2021 Feb; 11(2):507-518. PubMed ID: 33448693
[TBL] [Abstract][Full Text] [Related]
4. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
Furuhashi M
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
[TBL] [Abstract][Full Text] [Related]
5. Disruption of xanthine oxidoreductase gene attenuates renal ischemia reperfusion injury in mice.
Haga Y; Ohtsubo T; Murakami N; Noguchi H; Kansui Y; Goto K; Matsumura K; Kitazono T
Life Sci; 2017 Aug; 182():73-79. PubMed ID: 28625358
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of hypoxanthine and xanthine by obesity in a general population.
Furuhashi M; Koyama M; Higashiura Y; Murase T; Nakamura T; Matsumoto M; Sakai A; Ohnishi H; Tanaka M; Saitoh S; Moniwa N; Shimamoto K; Miura T
J Diabetes Investig; 2020 Jul; 11(4):878-887. PubMed ID: 31916414
[TBL] [Abstract][Full Text] [Related]
7. Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
Wang H; Xie L; Song X; Wang J; Li X; Lin Z; Su T; Liang B; Huang D
Front Immunol; 2022; 13():773001. PubMed ID: 35154100
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidoreductase knockout mice with high HPRT activity were not rescued by NAD
Hosoyamada M; Tomioka NH; Ohtsubo T; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1465-1473. PubMed ID: 32126884
[TBL] [Abstract][Full Text] [Related]
9. Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9.
Arakawa H; Amezawa N; Kawakatsu Y; Tamai I
Biol Pharm Bull; 2020; 43(11):1792-1798. PubMed ID: 33132325
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.
Washio KW; Kusunoki Y; Murase T; Nakamura T; Osugi K; Ohigashi M; Sukenaga T; Ochi F; Matsuo T; Katsuno T; Moriwaki Y; Yamamoto T; Namba M; Koyama H
Metabolism; 2017 May; 70():51-56. PubMed ID: 28403945
[TBL] [Abstract][Full Text] [Related]
11. Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta.
Seymour KJ; Roberts LE; Fini MA; Parmley LA; Oustitch TL; Wright RM
J Biol Chem; 2006 Mar; 281(13):8545-58. PubMed ID: 16452486
[TBL] [Abstract][Full Text] [Related]
12. Hypoxanthine Secretion from Human Adipose Tissue and its Increase in Hypoxia.
Nagao H; Nishizawa H; Tanaka Y; Fukata T; Mizushima T; Furuno M; Bamba T; Tsushima Y; Fujishima Y; Kita S; Funahashi T; Maeda N; Mori M; Fukusaki E; Shimomura I
Obesity (Silver Spring); 2018 Jul; 26(7):1168-1178. PubMed ID: 29877616
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidoreductase activity in marathon runners: potential implications for marathon-induced acute kidney injury.
Kosaki K; Kumamoto S; Tokinoya K; Yoshida Y; Sugaya T; Murase T; Akari S; Nakamura T; Nabekura Y; Takekoshi K; Maeda S
J Appl Physiol (1985); 2022 Jul; 133(1):1-10. PubMed ID: 35608201
[TBL] [Abstract][Full Text] [Related]
14. Arxula adeninivorans xanthine oxidoreductase and its application in the production of food with low purine content.
Jankowska DA; Trautwein-Schult A; Cordes A; Hoferichter P; Klein C; Bode R; Baronian K; Kunze G
J Appl Microbiol; 2013 Sep; 115(3):796-807. PubMed ID: 23773263
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidoreductase in cancer: more than a differentiation marker.
Battelli MG; Polito L; Bortolotti M; Bolognesi A
Cancer Med; 2016 Mar; 5(3):546-57. PubMed ID: 26687331
[TBL] [Abstract][Full Text] [Related]
16. Role of xanthine oxidoreductase in experimental acute renal-allograft rejection.
Sun K; Kiss E; Bedke J; Stojanovic T; Li Y; Gwinner W; Gröne HJ
Transplantation; 2004 Jun; 77(11):1683-92. PubMed ID: 15201667
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.
Agarwal A; Banerjee A; Banerjee UC
Crit Rev Biotechnol; 2011 Sep; 31(3):264-80. PubMed ID: 21774633
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidoreductase mediates membrane docking of milk-fat droplets but is not essential for apocrine lipid secretion.
Monks J; Dzieciatkowska M; Bales ES; Orlicky DJ; Wright RM; McManaman JL
J Physiol; 2016 Oct; 594(20):5899-5921. PubMed ID: 27357166
[TBL] [Abstract][Full Text] [Related]
19. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.
Ichida K; Amaya Y; Okamoto K; Nishino T
Int J Mol Sci; 2012 Nov; 13(11):15475-95. PubMed ID: 23203137
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously hypertensive rats.
Laakso J; Vaskonen T; Mervaala E; Vapaatalo H; Lapatto R
Life Sci; 1999; 65(25):2679-85. PubMed ID: 10622277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
